INOVIO PHARMACEUTICALS INC
INO·45773H409·US·Common Stock·Healthcare - Biotechnology-13D/G
INO (INOVIO PHARMACEUTICALS INC) is held by 48 institutional investors as of Q1 2026. Largest holders: FMR LLC ($16.3M), Janus Henderson Group Ltd. ($5.8M), VANGUARD CAPITAL MANAGEMENT LLC ($5M). Net institutional sentiment: Mixed.
48
Holders
Avg rating(14 Elite)
$43M
Total Value
50% (56)
Fund Consensus
23 buying - 23 selling
Who's Trading
ActivistHIHIGHBRIDGE CAPITAL MANAGEMENT LLC8.2%May 15, 2026
ActivistADAdage Capital Management, L.P.5.8%May 13, 2026
ActivistDTDeep Track Capital, LP2.4%Nov 14, 2025
ActivistSTStonepine Capital Management, LLC3.8%May 14, 2025
13F: Insider & Congress:
Showing 1-20 of 56
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer